A detailed history of Aptus Capital Advisors, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 262,810 shares of OCUL stock, worth $2.23 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
262,810
Previous 262,810 -0.0%
Holding current value
$2.23 Million
Previous $1.8 Million 27.21%
% of portfolio
0.04%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$4.2 - $8.69 $1.1 Million - $2.28 Million
262,810 New
262,810 $1.8 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.